ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
Renexxion will stream a presentation and hold one-to-one meetings as it advances naronapride toward global pivotal studies for gastroparesis.
- The H.C. Wainwright 28th Annual Global Investment Conference will convene September 14–16, 2026, at the Lotte New York Palace Hotel in New York City, bringing together public and private companies with institutional investors.
- Designed to connect companies with institutional investors, family offices, and analysts, the conference features company presentations, panel discussions, and one-on-one investor meetings across multiple sectors.
- Biotech companies including Renexxion, Inc., Lipocine Inc., and MindWalk Holdings Corp. will present clinical research and development pipelines, while technology firms showcase cybersecurity and AI infrastructure solutions.
- Registered attendees can access presentations, fireside chats, and webcasts on-demand via the conference platform, with early materials available beginning Friday, September 11, 2026, at 7:00 a.m. ET.
- Archived webcasts remain available for 90 days following the live event, supporting continued investor engagement and enabling those unable to attend in person to access company presentations remotely.
20 Articles
20 Articles
MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
AUSTIN, Texas — MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it is participating in the H.C. Wainwright 28th Annual Global Investment Conference, held September 14 – 16, 2026 at the Lotte New York Palace Hotel in New York, where a pre-recorded fireside chat with Chief Executive Officer Dr. Jennifer […]
Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference
SALT LAKE CITY, Sept. 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that Company management will present and meet with investors at the H.C. Wainwright 28th…
Intrusion Inc. Announces Participation in the H.C. Wainwright Annual Global Investment Conference
PLANO, TX / ACCESS Newswire / September 9, 2026 / Intrusion Inc. (NASDAQ:INTZ) ("Intrusion" or the "Company"), a provider of AI-powered cyberattack prevention, threat intelligence, and managed cybersecurity solutions, announced today that Tony Scott, CEO, and Kimberly Pinson, CFO, will…
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
NEW YORK and TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that…
Coverage Details
Bias Distribution
- 64% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
